Chengwei Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Chengwei Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 30, 2025	Full-Life Technologies	$77.0M Life Technologies - Debt / Series C	Wei Shen	Lapam Capital, Plaisance Capital Management, Prosperity7 Ventures, Sequoia Capital, Summer Capital, TruMed Investment
Dec 1, 2023	Perpetual Medicines	$8.0M Seed	Chengwei Capital	—
Nov 17, 2023	Jushu Biotech	$13.8M Pre-Series A	—	3E Bioventures Capital
Jun 14, 2022	Raythink Technology	$15.0M Series A	Pei Kang	Unicom Innovation Venture Capital
Dec 23, 2021	TandemAI	$25.0M Pre-Seed	David Wang, Chengwei Capital	—
Oct 28, 2019	Sensely	$15.0M Other Equity	Nadeem G. Khan	Mojo Partners, New Mountain Capital, Nippon Life Insurance Company, Pegasus Tech Ventures, Silicon Valley Bank, Sojitz Corporation, Susquehanna International Group, Zuellig Pharma
Jun 6, 2019	SiFive	$65.4M Series D	Chengwei Capital, Huami, Osage University Partners, Spark Capital, Stefan Dyckerhoff	Quinn Li
Jan 25, 2019	AInnovation	$59.1M Series A	CICC Capital	Sinovation Ventures
Aug 8, 2018	TOT BIOPHARM	$102.0M Series B	—	Cathay Capital, Center Laboratories Limited, Vivo Capital, Yuanta Asia Investment
May 22, 2018	AInnovation	$15.7M Other Equity	Chengwei Capital	Lee Kai-Fu
Apr 2, 2018	SiFive	$50.6M Series C	Chengwei Capital, Osage University Partners, Spark Capital, Stefan Dyckerhoff	Huami, Intel Capital, SK Telecom, Martin Fink
Feb 14, 2017	Sensely	$8.0M Series B	Richard Gu	Bioved Ventures, Fenox Venture Capital, Mayo Clinic, Stanford
Sep 14, 2016	oTMS	$25.0M Series B	Chen Weixing	Baidu, Matrix Partners China
Jul 1, 2016	Dotc United Group	$45.0M Series A	—	5Y Capital, BAI Capital, Banyan Capital, Lightspeed Venture Partners, Morningside Ventures
Jan 1, 2015	APUS Group	$100.0M Series B	Qiming Venture Partners, Chengwei Capital, SIG	Northern Light Venture Capital, Redpoint Ventures
Nov 1, 2013	Novasentis	$8.0M Series B	Chengwei Capital, Michael P.	—